Cost-effectiveness of losartan-based therapy in patients with hypertension and left ventricular hypertrophy: a UK-based economic evaluation of the Losartan Intervention for Endpoint reduction in hypertension (LIFE) study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples